Apexian’s Mark Kelley Receives Innovation Award

Apex Therapeutics’ Dr. Mark Kelley received the 2015 Innovation to Enterprise award on November 4, 2015 at the IUPUI Innovation to Enterprise Forum & Showcase in Indianapolis. The event highlights the research and creative successes of our faculty, research scientists, and students from across the campus.

The program featured an interactive look at the innovative & entrepreneurial projects arising from the research programs at IUPUI.

The goal of the IUPUI Innovation to Enterprise organization is to create and encourage the invention culture on campus, and serve as a ready source of support and information for faculty, staff, and students engaged in research with potential for commercial development.

Indiana University Research & Technology Corporation (IURTC) presents the IUPUI Innovation to Enterprise Forum & Showcase.

Award Presentation:
2015 Innovation to Enterprise Award
Mark R. Kelley, PhD / Chief Scientific Founder: Apexian Pharmaceuticals
Dr. Kelley is currently the Betty and Earl Herr Chair in Pediatric Oncology Research and Professor, Departments of Biochemistry & Molecular Biology and Pharmacology & Toxicology, Indiana University School of Medicine. He is also the Associate Director, Herman B Wells Center for Pediatric Research and the Associate Director for Basic Science Research at the IU Simon Cancer Center.

 

Read more about Innovation to Enterprise and award ceremony